Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tripepi

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|January 11, 2002
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective studyC Zoccali, S Bode-Böger, F Mallamaci, et al.
Kidney International|March 22, 2001
Diagnostic potential of cardiac natriuretic peptides in dialysis patientsF Mallamaci, C Zoccali, G Tripepi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2001
Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patientsG Enia, F Mallamaci, F A Benedetto, et al.
Journal of Nephrology|January 11, 2019
Novel markers of graft outcome in a cohort of kidney transplanted patients: a cohort observational studyC Alfieri, A Regalia, G Moroni, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 27, 2015
A genetic marker of hyperuricemia predicts cardiovascular events in a meta-analysis of three cohort studies in high risk patientsA Testa, S Prudente, D Leonardis, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 27, 2016
Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patientsC Zoccali, C Torino, G Curatola, et al.
Journal of Internal Medicine|July 16, 2003
Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failureC Zoccali, F Mallamaci, G Tripepi, et al.
European Journal of Clinical Investigation|June 20, 2003
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failureC Zoccali, F A Benedetto, F Mallamaci, et al.
Journal of Nephrology|August 6, 2000
Renal endothelin-1 is linked to changes in urinary salt and volume in essential hypertension. Salt Sensitivity Group of the Italian Society of HypertensionL S Malatino, I Bellanuova, A Cataliotti, et al.
American Journal of Hypertension|April 3, 2001
Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension. Salt Sensitivity Group of Italian Society of HypertensionF Cuzzola, F Mallamaci, G Tripepi, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|January 11, 2002
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective studyC Zoccali, S Bode-Böger, F Mallamaci, et al.
Kidney International|March 22, 2001
Diagnostic potential of cardiac natriuretic peptides in dialysis patientsF Mallamaci, C Zoccali, G Tripepi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2001
Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patientsG Enia, F Mallamaci, F A Benedetto, et al.
Journal of Nephrology|January 11, 2019
Novel markers of graft outcome in a cohort of kidney transplanted patients: a cohort observational studyC Alfieri, A Regalia, G Moroni, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 27, 2015
A genetic marker of hyperuricemia predicts cardiovascular events in a meta-analysis of three cohort studies in high risk patientsA Testa, S Prudente, D Leonardis, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 27, 2016
Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patientsC Zoccali, C Torino, G Curatola, et al.
Journal of Internal Medicine|July 16, 2003
Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failureC Zoccali, F Mallamaci, G Tripepi, et al.
European Journal of Clinical Investigation|June 20, 2003
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failureC Zoccali, F A Benedetto, F Mallamaci, et al.
Journal of Nephrology|August 6, 2000
Renal endothelin-1 is linked to changes in urinary salt and volume in essential hypertension. Salt Sensitivity Group of the Italian Society of HypertensionL S Malatino, I Bellanuova, A Cataliotti, et al.
American Journal of Hypertension|April 3, 2001
Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension. Salt Sensitivity Group of Italian Society of HypertensionF Cuzzola, F Mallamaci, G Tripepi, et al.
Pageof 7